Barclays Cuts Aspen Aerogels (NYSE:ASPN) Price Target to $13.00

Aspen Aerogels (NYSE:ASPN) had its target price decreased by Barclays from $25.00 to $13.00 in a report released on Wednesday morning,Benzinga reports. Barclays currently has an overweight rating on the construction company’s stock.

A number of other brokerages have also recently commented on ASPN. Roth Mkm decreased their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Craig Hallum decreased their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday. Finally, Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $22.44.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $8.04 on Wednesday. The stock has a market cap of $659.27 million, a PE ratio of 50.22 and a beta of 2.14. The company’s fifty day moving average is $11.75 and its 200 day moving average is $18.15. Aspen Aerogels has a 52 week low of $7.96 and a 52 week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Research analysts anticipate that Aspen Aerogels will post 0.22 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Large investors have recently modified their holdings of the stock. Quest Partners LLC boosted its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after purchasing an additional 5,361 shares in the last quarter. Sandia Investment Management LP bought a new stake in Aspen Aerogels during the fourth quarter worth about $89,000. Pursue Wealth Partners LLC bought a new stake in Aspen Aerogels during the third quarter worth about $222,000. Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels during the third quarter worth about $252,000. Finally, Kovitz Investment Group Partners LLC bought a new stake in Aspen Aerogels during the third quarter worth about $263,000. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.